Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost
- PMID: 39950009
- PMCID: PMC11822616
- DOI: 10.1017/ash.2025.17
Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost
Abstract
Redundant and low-value cerebrospinal fluid analysis for suspected meningitis can increase costs and antimicrobial use. Our diagnostic stewardship intervention limited available infectious disease cerebrospinal fluid assays to seven common tests, including a multiplex polymerase chain reaction panel. There was no significant difference in the cost of testing or clinical outcomes.
© The Author(s) 2025.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
References
-
- Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA 2022;328:2147–2154. - PubMed
-
- Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA 2017;318:607–608. - PubMed
-
- Banerjee R. Multiplex polymerase chain reaction testing to diagnose central nervous system infections—a doubled-edged sword. J Pediatr Infect Dis Soc 2022;11:124–125. - PubMed
-
- Morrison AR, Jones MC, Makowski CT, et al. Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis. Diagn Microbiol Infect Dis 2022;102:115571. - PubMed
LinkOut - more resources
Full Text Sources